Relief Therapeutics Holding AG
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Relief Therapeutics Holding AG's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 1% to $6,033,000. Profit margin reached -1627%. Total operating expenses were $114,941,000.

Profit Margin

Relief Therapeutics Holding AG (LSE:0QKQ.L): Profit margin
2014 19.49M -12.28M -63.01%
2015 256.11K -9.15M -3574.27%
2016 15K -16.83M -112226.67%
2017 0 -2.88M
2018 567K -436K -76.9%
2019 0 -7.46M
2020 0 -7.82M
2021 3.32M -34.70M -1045.02%
2022 6.08M -50.79M -835.22%
2023 6.03M -98.18M -1627.4%

0QKQ.L Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
6.03M6.08M3.32M00567K015K256.11K19.49M
Cost of revenue
1.92M18.10M11.90M01K55K3K211K2.08M12.68M
Gross profit
4.11M-12.02M-8.58M0-1K512K-3K-196K-1.82M6.80M
Operating exp.
Research and development
1.32M12.39M19.02M13.64M000000
Selling and marketing
2.2M3.30M365K2.65M349K346K989K40K030.06K
Total operating expenses
114.94M24.52M26.62M19.29M946K788K1.24M1.73M1.99M20.47M
Operating income
-110.82M-36.54M-35.21M-19.29M-947K-500K-1.24M-16.48M-3.81M-12.10M
Other income (expenses), net
-856K-17.76M-315K13.03M-11.21M84K-656K-325K0-17K
Income before tax
-111.68M-54.31M-35.52M-6.26M-12.16M-416K-1.90M-16.81M-4.36M-12.45M
Income tax expense
-13.50M-3.52M-820K1.56M-4.70M20K986K20K-87.53K-170.74K
Net income
-98.18M-50.79M-34.70M-7.82M-7.46M-436K-2.88M-16.83M-9.15M-12.28M
Earnings per share
Basic EPS
-8.35-4.8-3.86-1.3-1.42-0.08-0.58-5.32-6.24-10.34
Diluted EPS
-8.35-4.8-3.86-1.3-1.42-0.08-0.58-5.32-6.24-10.34
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source